Dept. of Orthopedics and Surgery, Fracture Liaison Service, Reinier de Graaf Gasthuis, Delft, the Netherlands.
Bare Statistics, the Netherlands. Electronic address: http://www.barestatistics.nl.
Int J Orthop Trauma Nurs. 2021 Nov;43:100899. doi: 10.1016/j.ijotn.2021.100899. Epub 2021 Aug 30.
Fracture Liaison Service (FLS) managed secondary fracture prevention services have been hampered during the COVID-19 pandemic. A challenging opportunity is to use pulse-echo ultrasound (P-EU) in the plaster room. The study had two objectives: can P-EU help our decision to justly avoid DXA/VFA scans in plaster treated women (50-70 years) after fracture and whether its use can encourage or nudge all plaster treated patients (>50 years) who need DXA/VFA scans.
1307 patients (cohort: pre-COVID-19) and 1056 patients (cohort: peri-COVID-19), each of them ≥ 50 years after recent fracture, were studied. Only in women aged 50-70 years, we used a P-EU decision threshold (DI) >= 0.896 g/cm to rule out further analysis by means of DXA/VFA. All other plaster patients received P-EU as part of patient information. Peri-Covid-19, all performed DXA/VFA scans were counted until three months post-study closure. By then each patient still waiting for a DXA/VFA had received a scan.
Peri-COVID-19, 69 out of 191 plaster-treated women aged 50-70 years were ruled out (36%), for plaster and not in-plaster treated women aged 50-70 years, it was 27%. Comparing all peri-to pre-COVID-19 plaster-treated women and men, a significant P-EU nudging effect was found (difference in proportions: 8.8%) P = .001.
The combination of patient information and P-EU in the plaster room is effective to reduce DXA/VFA scans and allow extra patients to undergo DXA/VFA. After all, more than a quarter of 50-70 years old women in plaster did not need to be scanned.
在 COVID-19 大流行期间,骨折联络服务(FLS)管理的继发性骨折预防服务受到了阻碍。一个具有挑战性的机会是在石膏室中使用脉冲回波超声(P-EU)。该研究有两个目标:P-EU 是否可以帮助我们决定在石膏治疗的女性(50-70 岁)骨折后合理避免 DXA/VFA 扫描,以及其使用是否可以鼓励或推动所有需要 DXA/VFA 扫描的石膏治疗患者(>50 岁)。
研究了 1307 名患者(队列:COVID-19 前)和 1056 名患者(队列:COVID-19 期间),他们均在最近骨折后≥50 岁。仅在 50-70 岁的女性中,我们使用 P-EU 决策阈值(DI)≥0.896 g/cm 来排除进一步的 DXA/VFA 分析。所有其他石膏患者均接受 P-EU 作为患者信息的一部分。在 COVID-19 期间,直到研究结束后三个月,对所有进行的 DXA/VFA 扫描进行了计数。到那时,每个仍在等待 DXA/VFA 的患者都已接受了扫描。
在 COVID-19 期间,191 名 50-70 岁石膏治疗女性中有 69 人被排除在外(36%),而 50-70 岁非石膏治疗女性中则有 27%。比较所有 COVID-19 期间的石膏治疗女性和男性与 COVID-19 前相比,发现 P-EU 推动效应显著(比例差异:8.8%)P=0.001。
在石膏室中结合患者信息和 P-EU 可有效减少 DXA/VFA 扫描,并允许更多患者接受 DXA/VFA。毕竟,超过四分之一的 50-70 岁石膏治疗女性无需扫描。